Company intelligence / Profile preview

Beijing Immunopharm Technology

Beijing, Beijing, China
Ownership
Private
Development stage
Other
01

Overview

Beijing Immunopharm Technology is a clinical-stage biotechnology company based in Beijing, China, specializing in the development of innovative therapeutic vaccines. The company leverages its proprietary DNA vaccine platform and advanced electroporation delivery technology to target chronic infectious diseases and oncology. Its lead candidate is a therapeutic DNA vaccine for Chronic Hepatitis B, which has progressed into Phase 2 clinical trials. Founded by experts in immunology, the company aims to provide functional cures for persistent viral infections like HBV and HIV through T-cell mediated immune responses. The firm maintains a strong focus on translational medicine and collaborative research to advance its pipeline of immunotherapies.

Therapeutic areas
OncologyInfectious Diseases
Modalities
DNA vaccineVaccineImmunotherapy
Industry
Biotech
02

Partnerships

Fudan University

Beyond the preview

Go deeper on Beijing Immunopharm Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Immunopharm Technology.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call